Clinical Study
Levels of Salivary IFN-gamma, TNF-Alfa, and TNF Receptor-2 As Prognostic Markers in (Erosive) Oral Lichen Planus
Table 2
The change of IFN-γ, TNF-α, and TNFR-2 salivary levels in ELP patients treated with prednisone and control subjects.
| | | IFN-γ | TNF-α | TNFR-2 |
| ELP before treatment | Mean ± SD | 23.953 ± 5.33 | 44.485 ± 16.81 | 350.4 ± 330.89 | Median | 18.30 | 55.60 | 1029 |
| ELP after treatment | Mean ± SD | 17.237 ± 5.68 | 21.33 ± 17.21 | 14.0 ± 11.39 | Median | 15.39 | 54.30 | 31 |
| Control | Mean ± SD | 6.41 ± 2.53 | 1.405 ± 0.25 | 45 ± 13.82 | Median | 6.09 | 0.90 | 43 |
| Before versus after | value | | | |
| Before versus control | value | | | |
|
|